Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Feb 21;155(6):2606–2614.e5. doi: 10.1016/j.jtcvs.2018.01.100

Table 1.

Univariate demographic, covariate variables, and outcome measures by admission location.

Variable/Outcome NICU n=9,493 (48%) CICU N=7,830 (39%) PICU N=2,661 (13%) p-value
Demographics
Male gender, n (%) 5,669 (60%) 4,675 (60%) 1,593 (60%) 0.9
Race, n (%) <0.001
 Non-Hispanic black 859 (9%) 870 (11%) 201 (8%)
 Hispanic 1,451 (15%) 1,038 (13%) 556 (21%)
 Non-Hispanic white 4,772 (50%) 3,964 (51%) 1,387 (52%)
 Asian 134 (1%) 65 (1%) 24 (1%)
 Missing or other 2,277 (24%) 1,893 (24%) 493 (19%)
Payor <0.001
 Private 3,734 (39%) 2,816 (36%) 975 (37%)
 Government 4,595 (48%) 3,532 (45%) 1,423 (53%)
 Other 1,164 (12%) 1,482 (19%) 263 (10%)
Patient Characteristics
Age at admission, days, mean ± SD 1.9±3.9 3.2±5.5 5.9±7.59 <0.001
Age at admission, days, Median (IQR) 0 (0,2) 0 (0,3) 0 (0,9) <0.001
Age at admission, n (%)* <0.001
 0–1 days 6,996 (74%) 4,858 (62%) 1,284 (48%)
 2–7 days 1,706 (18%) 1,778 (23%) 543 (20%)
 8–14 days 556 (6%) 687 (9%) 412 (15%)
 15+ days 235 (2%) 506 (6%) 422 (16%)
Admission year, n (%) <0.001
 2003 85 (1%) 43 (1%) 12 (0.5%)
 2004 858 (9%) 665 (8%) 234 (9%)
 2005 934 (10%) 736 (9%) 295 (11%)
 2006 1,022 (11%) 891 (11%) 305 (11%)
 2007 1,097 (12%) 830 (11%) 283 (11%)
 2008 1,176 (12%) 795 (10%) 211 (8%)
 2009 1,037 (11%) 658 (8%) 213 (8%)
 2010 967 (10%) 677 (9%) 192 (7%)
 2011 875 (9%) 815 (10%) 318 (12%)
 2012 756 (8%) 861 (11%) 301 (11%)
 2013 686 (7%) 859 (11%) 297 (11%)
Prostaglandin use, n (%) 7,428 (78%) 6,146 (78%) 2,076 (78%) 0.9
RACHS-1 score <0.001
 2 1,979 (21%) 1,566 (20%) 736 (28%)
 3 3,505 (37%) 2,920 (37%) 880 (33%)
 4 2,620 (28%) 1,958 (25%) 696 (26%)
 5 55 (1%) 44 (1%) 21 (1%)
 6 1,334 (14%) 1,342 (17%) 328 (12%)
Risk Factors
Prematurity, n (%) 1,428 (15%) 720 (9%) 195 (7%) <0.001
Low birth weight, n (%) 1,196 (12%) 567 (7%) 149 (6%) <0.001
Other genetic or major non-cardiac defect, n(%) 1,409 (15%) 884 (11%) 263 (10%) <0.001
Heterotaxy syndrome, n (%) 601 (6%) 358 (5%) 117 (4%) <0.001
Center data
Census region, n (%) <0.001
 Midwest 2,866 (30%) 886 (11%) 784 (29%)
 Northeast 1,436 (15%) 1,912 (24%) 237 (9%)
 South 2,713 (29%) 2,853 (36%) 1,058 (40%)
 West 2,478 (26%) 2,179 (28%) 582 (22%)
Center volume, n (%) <0.001
 Lowest tertile, <50 cases/ yr 3,146 (33%) 2,104 (27%) 760 (29%)
 Middle tertile, 50–75 cases/yr 3,095 (33%) 4,958 (63%) 372 (14%)
 Highest tertile, > 75 cases/ yr 3,252 (34%) 768 (10%) 1,529 (57%)
Complications/Infections
Chylothorax, n (%) 558 (6%) 290 (4%) 123 (5%) <0.001
Medical complications, n (%) 165 (2%) 108 (1%) 24 (1%) 0.004
Surgical complications, n (%) 4,720 (50%) 3,811 (49%) 1,213 (46%) 0.001
Infectious complications, n (%) 3,678 (39%) 2,186 (28%) 787 (30%) <0.001
ECMO, n (%) 630 (7%) 556 (7%) 210 (8%) 0.07
Outcomes
Total hospital cost, median (IQR) $106,470 ($57,830, $185,500) $100,202 ($63,890, 169,410 $118,480 ($75,110, $201,410) <0.001
Total hospital LOS, median (IQR) 24 (15,42) 17 (11,30) 18 (10,33) <0.001
ICU LOS, median (IQR) 18 (11,34) 11 (6,20) 13 (7,23) <0.001
Days of mechanical ventilation, median (IQR) 6 (3,13) 6 (3,10) 6 (3,11) <0.001
Preoperative LOS, median (IQR) 5 (2,8) 3 (1,5) 3 (1,6) <0.001
Postoperative LOS, median (IQR) 19 (10, 35) 14 (8, 26) 14 (7,28) <0.001
Mortality, n (%) 830 (9%) 600 (8%) 224 (8%) 0.04
*

age of admission not available for 1 CICU subject.

definition available in Appendix 1.

total cost available for 18,065 (90%) of total cohort

NICU - Neonatal intensive care unit, CICU - cardiac intensive care unit, PICU - Pediatric intensive care unit, SD – standard deviation. RACHS-1 – risk adjusted congenital heart surgery, ECMO- extracorporeal membrane oxygenation, IQR – interquartile range, ICU – intensive care unit, LOS – length of stay